Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents

Journal of Medicinal Chemistry
Maria V PapadopoulouJean-Robert Ioset


A series of novel 3-nitro-1H-1,2,4-triazole-based (and in some cases 2-nitro-1H-imidazole-based) amides and sulfonamides were characterized for their in vitro antitrypanosomal and antileishmanial activities as well as mammalian toxicity. Out of 36 compounds tested, 29 (mostly 3-nitro-1H-1,2,4-triazoles) displayed significant activity against Trypanosoma cruzi intracellular amastigotes (IC(50) ranging from 28 nM to 3.72 μM) without concomitant toxicity to L6 host cells (selectivity 66-2782). Twenty-three of these active compounds were more potent (up to 58-fold) than the reference drug benznidazole, tested in parallel. In addition, nine nitrotriazoles which were moderately active (0.5 μM ≤ IC(50) < 6.0 μM) against Trypanosoma brucei rhodesiense trypomastigotes were 5-31-fold more active against bloodstream-form Trypanosoma brucei brucei trypomastigotes engineered to overexpress reduced nicotinamide adenine dinucleotide dependent nitroreductase. Finally, three nitrotriazoles displayed a moderate activity against the axenic form of Leishmania donovani . Therefore, 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides are potent antitrypanosomal agents.


Jan 1, 1990·Chemico-biological Interactions·R Docampo
Apr 1, 1993·Drugs·S V Seremetis, L M Aledort
Feb 10, 1999·Biochemical Pharmacology·C ViodéJacques Périé
May 7, 2002·Memórias do Instituto Oswaldo Cruz·José Rodriques Coura, Solange L de Castro
Mar 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shane R WilkinsonIan Cheeseman
Apr 3, 2008·The Journal of Clinical Investigation·Ken StuartRick Tarleton
Aug 19, 2008·European Journal of Medicinal Chemistry·Lucía BoianiMercedes González
Feb 12, 2009·European Journal of Medicinal Chemistry·Emanuel Hernández-NúñezGabriel Navarrete-Vazquez
Aug 27, 2009·PLoS Neglected Tropical Diseases·Solomon NwakaRobert Ridley
Sep 24, 2009·Memórias do Instituto Oswaldo Cruz·Maria de Nazaré C SoeiroSolange Lisboa de Castro
Nov 26, 2009·Acta Tropica·Gabriel A Schmunis, Zaida E Yadon
Dec 24, 2009·Antimicrobial Agents and Chemotherapy·Belinda S HallShane R Wilkinson
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Cristian Ruiz, Stuart B Levy
Apr 20, 2010·Lancet·Anis RassiJosé Antonio Marin-Neto
Jul 31, 2010·The Lancet Infectious Diseases·François-Xavier LescureGilles Pialoux
Aug 4, 2010·Antimicrobial Agents and Chemotherapy·Chris BotShane R Wilkinson
Nov 3, 2010·International Journal of Health Geographics·Pere P SimarroJean G Jannin
Feb 25, 2011·The Journal of Biological Chemistry·Belinda S HallShane R Wilkinson
May 31, 2011·Current Topics in Medicinal Chemistry·Shane R WilkinsonBelinda S Hall
May 31, 2011·Bioorganic & Medicinal Chemistry Letters·Longqin HuShane R Wilkinson
Oct 26, 2011·Journal of Medicinal Chemistry·Maria V PapadopoulouEls Torreele
Feb 24, 2012·Nature·Eric S Starbuck
Oct 25, 2012·Southern Med Review·Verica Ivanovska


Sep 10, 2013·Bioorganic & Medicinal Chemistry·Maria V PapadopoulouJean-Robert Ioset
Jul 30, 2014·European Journal of Medicinal Chemistry·Anna KryshchyshynRoman Lesyk
Oct 23, 2013·Future Medicinal Chemistry·Maria V PapadopoulouAna Rodriguez
Mar 5, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Da-Chuan LiuZhe-Shan Quan
Aug 7, 2013·Acta Tropica·Grace Buchanan-KilbeyRachel Ashworth
May 31, 2016·Expert Opinion on Drug Discovery·Joachim Müller, Andrew Hemphill
Sep 23, 2014·European Journal of Medicinal Chemistry·Maria V PapadopoulouMarcel Kaiser
Sep 8, 2015·Bioorganic & Medicinal Chemistry·Maria V PapadopoulouJean-Robert Ioset
Sep 14, 2015·European Journal of Medicinal Chemistry·Maria V PapadopoulouMarcel Kaiser
Mar 1, 2017·Antimicrobial Agents and Chemotherapy·Maria V PapadopoulouMaria Terezinha Bahia
Feb 18, 2015·Molecular Microbiology·James A SullivanShane R Wilkinson
Oct 18, 2019·Frontiers in Chemistry·Florence Uchenna EzeSunday N Okafor
Oct 31, 2018·Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents·Amer H TarawnehStephen J Cutler
Jul 28, 2017·Current Medicinal Chemistry·Susimaire Pedersoli MantoaniIvone Carvalho

Related Concepts

Nitrobenzene nitroreductase
Leishmania donovani
Nitrated Compounds
Structure-Activity Relationship
Trypanocidal Agents

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

© 2021 Meta ULC. All rights reserved